Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck mSD Employee Stock Purchase Plan (Form 11-K) — Net Investment Gain (Loss) from Master Trust ($M) ($M)
Form 11-K
Latest, FY2025
85,058
Period ended Dec 31, 2025
Change on a year earlier
+42.0%
59,909 in FY2024
History
4 years
Since FY2022
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | MSD Employee Stock Purchase Plan (Form 11-K) — Net Investment Gain (Loss) from Master Trust ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 85,058 | +42.0% | Form 11-K (mrk-20260624.htm, filed 2026-06-24) ↗ |
| FY2024 | Dec 31, 2024 | 59,909 | -11.8% | Form 11-K (a11-k_msdemployeestockpurc.htm, filed 2025-06-27) ↗ |
| FY2023 | Dec 31, 2023 | 67,922 | -244.4% | Form 11-K (a11-k_msdemployeestockpurc.htm, filed 2024-06-25) ↗ |
| FY2022 | Dec 31, 2022 | -47,036 | – | Form 11-K (a11-k_msdemployeestockpurc.htm, filed 2023-06-27) ↗ |
Cite this data
StockData. (2026). Merck MSD Employee Stock Purchase Plan (Form 11-K) — Net Investment Gain (Loss) from Master Trust ($M) ($M), annual FY2022–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/plan11k_espp_inv_inc
See every metric in the Merck KPI table. Data updated Oct 26, 2026.